Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy

Brain metastasis from differentiated thyroid carcinoma responding to radioiodine therapy

Brain metastasis (BM) occurs only in about 1% of differentiated thyroid carcinoma (DTC) cases. Although DTC generally has a good prognosis, once BM develops, the mortality rate significantly increases up to 78%. BM is usually treated by surgical resection or external radiotherapy, whereas radioactiv...

Full description

Saved in:
Bibliographic Details
Main Authors: Leo Hashimoto, Shiro Watanabe, Mungunkhuyag Majigsuren, Kenji Hirata, Junki Takenaka, Rina Kimura, Hiroshi Ishii, Kohsuke Kudo
Format: Article
Language:English
Published: Mashhad University of Medical Sciences 2025-07-01
Series:Asia Oceania Journal of Nuclear Medicine and Biology
Subjects:
thyroid cancer
radioiodine
brain metastasis
Online Access:https://aojnmb.mums.ac.ir/article_25946_879705d895cc7c4aed3b5f5b775725ae.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items